BOLD vs CUBE
Boundless Bio, Inc. Common Stock (BOLD) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BOLD and CUBE stock pages for the full models.
Not investment advice.